Search the Newsreel

Omeros surges 13% on strong earnings and revenue beat

Omeros Corporation (NASDAQ:OMER) reported second-quarter results that significantly surpassed analyst expectations, driven by strong sales of its new TA-TMA treatment, YARTEMLEA. The company posted adjusted earnings per share of $0.02 and revenue of $28.5 million, significantly beating estimates. Shares of Omeros surged 13% in …

OMEROS ($OMER) Releases Q2 2026 Earnings, Stock Rises

Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update

Spero Therapeutics announced its Q2 2026 operating results, highlighting several key achievements. These include an exclusive license agreement with Innovent Biologics for SP001, the FDA approval of Utebzi™ for complicated urinary tract infections, and a $105 million non-recourse financing deal. The company also appointed …

MoneyHero Ltd (MNY): TD Securities reports 6.8% beneficial stake via warrants

TD Securities (USA) LLC has reported a 6.8% beneficial ownership stake in MoneyHero Ltd (MNY) through warrants. This stake, totaling 2,263,847 Class A Ordinary Shares, is exercisable at $11.50 per share. The percentage is calculated based on 31,178,380 outstanding Class A Ordinary Shares as …

BRIEF-Omeros Corporation Q2 EPS USD 0.18

Omeros Corporation reported Q2 EPS of USD 0.18. This brief announcement was made available via Reuters and highlighted on TradingView News.

Vertical Aerospace (EVTL), Why Is It Back In The Spotlight?

Vertical Aerospace (EVTL) has recently completed a US$35.0 million composite units offering, issuing 33,333,334 equity and derivative units at US$1.05 each. This capital raise follows a period of significant share price decline, prompting investors to assess if the current discounted price is attractive. The …

REGN Stockholders May Be Entitled to Lead the Class Action Lawsuit Against Regeneron Pharmaceuticals, Inc. - Contact Robbins LLP for Information About Becoming the Lead Plaintiff

Robbins LLP is reminding investors who purchased Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between August 1, 2025, and May 15, 2026, about a securities class action lawsuit. The lawsuit alleges that Regeneron misled investors regarding its Phase 3 Fianlimab-Libtayo clinical trial for advanced melanoma, …

Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman Sobol Shapiro LLP

Hagens Berman Sobol Shapiro LLP has filed a securities class action lawsuit against Regeneron Pharmaceuticals (NASDAQ: REGN) on behalf of investors who suffered substantial losses. The lawsuit stems from surprising revelations about a failed Phase 3 clinical trial for a melanoma therapy, which caused …

Earnings Flash (OMER) Omeros Corporation Reports Q2 Revenue $28.5M, vs. FactSet Est of $12.7M

Omeros Corporation (OMER) announced Q2 revenue of $28.5 million, significantly surpassing FactSet's estimate of $12.7 million. The company, which is a clinical-stage biopharmaceutical firm, focuses on developing therapeutics for complement-mediated diseases, cancers, and addictive disorders. They also reported earnings results for the second quarter …

Firefly Aerospace Q2 Earnings Call Focuses on Backlog and Alpha Ramp

Firefly Aerospace's Q2 2026 earnings call highlighted strong demand for its lunar, defense, and launch programs, with a focus on backlog conversion and increasing Alpha launch rates. The company reported a narrower non-GAAP loss per share and revenues exceeding estimates, primarily driven by Spacecraft …

Park Aerospace CEO Brian Shore Executes Stock Option Exercises and Sells 76,250 Shares Over Two Days

Brian E. Shore, CEO of Park Aerospace Corp (NASDAQ: PKE), executed stock option exercises and subsequent sales of 76,250 shares over two days, August 10 and 11, 2026. These transactions involved exercising options at various strike prices and selling shares at weighted average prices …

Firefly Aerospace wins 6th moon mission amid surge in commercial space demand

Firefly Aerospace's CEO Jason Kim discusses how the company is attracting talent and competing with SpaceX and Rocket Lab by focusing on bold missions, production expansion, and a strong company culture. He highlights their recent success with a lunar lander and the securing of …

Halliburton, TechnipFMC, Antero Resources, APA Corporation, and Transocean Stocks Trade Up, What You Need To Know

Halliburton, TechnipFMC, Antero Resources, APA Corporation, and Transocean Stocks Trade Up, What You Need To Know What Happened? A number of stocks jumped in the morning session after Brent crude failed to break below $80 and rebounded to the mid-$80s, as traders kept a …

Analysts Offer Insights on Industrial Goods Companies: Aaon (AAON) and Bridger Aerospace Group Holdings (BAER)

Analysts have issued bullish sentiments for two industrial goods companies: Aaon (AAON) and Bridger Aerospace Group Holdings (BAER). William Blair maintained a Buy rating for Aaon, while Stifel Nicolaus maintained a Buy rating for Bridger Aerospace, with both companies showing significant upside potential according …

Does Firefly Aerospace (FLY) Have A Bigger Defense Role After Its $93.7 Million Win?

EagleRock Land (NYSE:EROK) Trading Down 6.3% Following Weak Earnings

AEROVIRONMENT, INC. (NASDAQ: AVAV) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty

Bernstein Liebhard LLP has announced an investigation into potential breaches of fiduciary duty by directors and officers of AeroVironment, Inc. (NASDAQ: AVAV). The firm is encouraging shareholders who purchased shares before June 25, 2025, to contact them to discuss their legal rights regarding whether …

Antero Resources (NYSE:AR) Price Target Raised to $47.00 at Benchmark

Benchmark has increased its price target for Antero Resources (NYSE:AR) to $47.00 from $44.00, maintaining a "buy" rating and suggesting a 24.35% upside. The company currently holds a "Moderate Buy" consensus rating among analysts with an average target price of $48.71. Antero Resources stock …

REGENERNON PHARMACEUTICALS, INC. INVESTORS WITH LOSSES HAVE

Bernstein Liebhard LLP reminds investors of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) with losses that they have until September 14, 2026, to join a securities class action lawsuit. The lawsuit alleges that Regeneron made false and misleading statements between August 1, 2025, and May 15, …

Valero Energy Corporation (VLO) Hit a 52 Week High, Can the Run Continue?

Have you been paying attention to shares of Valero Energy (VLO)? Shares have been on the move with the stock up 7.5% over the past month. The stock hit a new 52-week high of $324.38 in the previous session. Valero Energy has gained 99% …

FLY Stock Climbs Over 4% During Wednesday Pre-Market - Firefly Aerospace (NASDAQ:FLY)

Zero2IPO Holdings Returns to Profit on Higher Revenue and Margins

The Technical Signals Behind (PKE) That Institutions Follow

This article analyzes Park Aerospace Corp. (PKE) with a focus on institutional trading signals. It highlights a near-term neutral sentiment amidst mid and long-term strength, an exceptional risk-reward setup, and provides three distinct AI-generated trading strategies: Position Trading, Momentum Breakout, and Risk Hedging. The …

Regeneron Pharmaceuticals, Inc. Notice of September 14,

Hagens Berman Sobol Shapiro LLP has filed a securities class action lawsuit against Regeneron Pharmaceuticals (NASDAQ: REGN) on behalf of investors who purchased shares between August 1, 2025, and May 15, 2026. The lawsuit alleges that Regeneron made misleading statements regarding a failed Phase …

Better Value & Growth: INCY, HALO Top Regeneron Pharmaceuticals Stock

Are Wall Street Analysts Bullish on Valero Energy Stock?

The logo of Valero Energy on the screen of an exchange_ By maurice norbert Valero Energy Corporation (VLO), headquartered in San Antonio, Texas, manufactures, markets, and distributes petroleum-based and low-carbon liquid transportation fuels and petrochemical products. Valued at $90.7 billion by market cap, the …

Heron Incurs Wider Loss In Q2; Withdraws 2026 Guidance Amid Patent Litigation Over CINVANTI

(RTTNews) - Heron Therapeutics Inc. (HRTX), a commercial-stage biotechnology company, on Monday released second quarter financial results noting a higher loss due to increased sales expenses and decreased sales of oncology drugs. Heron markets various therapeutics, including ZYNRELEF, an extended-release local anesthetic, APONVIE for …

Insight Wealth Strategies LLC Has $5.46 Million Stock Position in Regeneron Pharmaceuticals, Inc. $REGN

Insight Wealth Strategies LLC increased its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 26.9% in the second quarter, bringing its total holdings to $5.46 million. Regeneron reported strong quarterly results with significant revenue growth and beat EPS estimates, maintaining a "Moderate Buy" consensus rating from …

Regeneron, Tenet leads top healthcare companies with highest earnings beats (XLV:NYSEARCA)

Regeneron Pharmaceuticals and Tenet Healthcare lead the healthcare sector with the highest positive earnings per share surprises, according to an analysis of corporate earnings. Other companies with significant beats include Eli Lilly, Biogen, and UnitedHealth. While positive EPS surprises indicate operational resilience and exceeding …

Tema ETFs LLC Has $67.06 Million Stock Holdings in Firefly Aerospace, Inc. $FLY

How Regeneron Pharmaceuticals Went From Cheaper Than Incyte To The Pricier Stock

Regeneron Pharmaceuticals (REGN) now trades at a premium compared to Incyte (INCY), a reversal from a year ago. Regeneron's premium is attributed to its scale, blockbuster drugs like Dupixent and EYLEA HD, and a deep pipeline of approximately 50 clinical programs, despite slower growth …

Handelsbanken Fonder AB Trims Stock Position in Regeneron Pharmaceuticals, Inc. $REGN

Handelsbanken Fonder AB significantly reduced its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 58.1% in the second quarter, selling 72,708 shares and leaving them with 52,328 shares valued at $32,629,000. This move comes as other institutional investors have both increased and decreased their holdings in …

China Aerospace International Sets August Board Meeting to Review Interim Results

Hindustan Aeronautics Q1 results: HAL profit rises 15% YoY to ₹1,581 crore, revenue climbs 14%; check key numbers

Royal Bank of Canada Raises Stake in Firefly Aerospace, Inc. $FLY

Citi Sticks to Its Buy Rating for Antero Resources (AR)